This company listing is no longer active
このページの翻訳は実験的なもので、現在 開発中です。お待ちしております！
Satsuma Pharmaceuticals 過去の業績
過去 基準チェック /06
Satsuma Pharmaceuticals's earnings have been declining at an average annual rate of -33.2%, while the Pharmaceuticals industry saw earnings growing at 19.4% annually.
主要情報
-33.2%
収益成長率
46.0%
EPS成長率
| Pharmaceuticals 業界の成長 | 7.3% |
| 収益成長率 | n/a |
| 株主資本利益率 | -172.2% |
| ネット・マージン | n/a |
| 前回の決算情報 | 31 Mar 2023 |
最近の業績更新
更新なし
Recent updates
収支内訳
Satsuma Pharmaceuticals の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 31 Mar 23 | 0 | -65 | 14 | 40 |
| 31 Dec 22 | 0 | -70 | 15 | 44 |
| 30 Sep 22 | 0 | -62 | 16 | 47 |
| 30 Jun 22 | 0 | -61 | 15 | 46 |
| 31 Mar 22 | 0 | -56 | 14 | 42 |
| 31 Dec 21 | 0 | -51 | 14 | 38 |
| 30 Sep 21 | 0 | -48 | 13 | 35 |
| 30 Jun 21 | 0 | -47 | 14 | 33 |
| 31 Mar 21 | 0 | -46 | 13 | 34 |
| 31 Dec 20 | 0 | -48 | 12 | 36 |
| 30 Sep 20 | 0 | -46 | 11 | 36 |
| 30 Jun 20 | 0 | -42 | 8 | 35 |
| 31 Mar 20 | 0 | -37 | 7 | 32 |
| 31 Dec 19 | 0 | -28 | 5 | 24 |
| 30 Sep 19 | 0 | -20 | 3 | 17 |
| 30 Jun 19 | 0 | -13 | 2 | 11 |
| 31 Mar 19 | 0 | -8 | 1 | 7 |
| 31 Dec 18 | 0 | -7 | 1 | 6 |
質の高い収益: 1LV is currently unprofitable.
利益率の向上: 1LV is currently unprofitable.
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: 1LV is unprofitable, and losses have increased over the past 5 years at a rate of 33.2% per year.
成長の加速: Unable to compare 1LV's earnings growth over the past year to its 5-year average as it is currently unprofitable
収益対業界: 1LV is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (9.4%).
株主資本利益率
高いROE: 1LV has a negative Return on Equity (-172.21%), as it is currently unprofitable.